| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:55312179:2772 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:55312179:2772?format=raw |
LEADER: 02772fam a2200409 a 4500
001 4050614
005 20221027024615.0
008 950717t19951995ne a b 001 0 eng c
010 $a 95031820
020 $a0792388887 (casebound : alk. paper)
035 $a(OCoLC)32969069
035 $a(OCoLC)ocm32969069
035 $9ALF2079HS
035 $a(NNC)4050614
035 $a4050614
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRC692$b.H38 1995
060 10 $aW1 DE997VME v.174 1995$aQU 95 H431 1995
082 00 $a616.1/36$220
245 00 $aHDL deficiency and atherosclerosis /$cedited by G. Assmann.
260 $aDordrecht ;$aBoston :$bKluwer Academic Publishers,$c[1995], ©1995.
300 $ax, 84 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aDevelopments in cardiovascular medicine ;$v174
504 $aIncludes bibliographical references and index.
505 00 $g1.$tMolecular genetics approach to lipoprotein metabolism disorders /$rH. Funke, H. Wiebusch, S. Rust and G. Assmann --$g2.$tRole of high density lipoprotein subclasses in reverse cholesterol transport /$rA. von Eckardstein, Y. Huang and G. Assmann --$g3.$tConnection between cholesterol efflux and atherosclerosis /$rJ. C. Fruchart, C. De Geteire, B. Delfy and G. R. Castro --$g4.$tHDLC as a therapeutic target in coronary disease: current concepts and future directions /$rB. G. Brown, Xue-Qiao Zhao, V. M. G. Maher, A. Chait, M. Cheung, L. D. Fisher and J. Albers --$g5.$tIntracellular cholesterol transport /$rU. Seedorf, P. Brysch, T. Engel, S. Scheek, M. Raabe, M. Fobker, T. Szyperski, K. Wuthrich, N. Maea and G. Assmann --$g6.$tApolipoprotein E and Alzheimer's disease /$rR. W. Mahley --$g7.$tHDL metabolism and atherogenesis in genetically modified mice /$rN. Maeda, S. H. Zhang and R. L. Reddick --
505 80 $g8.$tGene therapy for the genetic dyslipoproteinaemias /$rH. B. Brewer, Jr., D. R. Brown, V. S. Kashyap, D. Applebaum-Bowden, J. M. Hoeg, N. Maeda and S. Santamarina-Fojo.
650 0 $aAtherosclerosis$xMolecular aspects.
650 0 $aHigh density lipoproteins$xMetabolism$xDisorders.
650 0 $aHypolipoproteinemia.$0http://id.loc.gov/authorities/subjects/sh86004097
650 12 $aLipoproteins, HDL$xdeficiency.$0https://id.nlm.nih.gov/mesh/D008075Q000172
650 22 $aLipoproteins, HDL$xmetabolism.$0https://id.nlm.nih.gov/mesh/D008075Q000378
650 22 $aAtherosclerosis$xmetabolism.$0https://id.nlm.nih.gov/mesh/D050197Q000378
700 1 $aAssmann, G.$q(Gerd)$0http://id.loc.gov/authorities/names/n85812408
830 0 $aDevelopments in cardiovascular medicine ;$vv. 174.$0http://id.loc.gov/authorities/names/n42009022
852 00 $boff,hsl$hRC692$i.H38 1995